Avoro Capital Advisors LLC 13D/13G Filings for Blueprint Medicines Corporation (BPMC)

Avoro Capital Advisors LLC 13D and 13G filings for Blueprint Medicines Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
09:30 am
Purchase
2025-03-3113GBlueprint Medicines Corporation
BPMC
Avoro Capital Advisors LLC3,850,000
6.000%
3,850,000increase
(New Position)
Filing